World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 17 October 2012
Main ID:  NCT01368939
Date of registration: 07/06/2011
Primary sponsor: Hamilton Health Sciences Corporation
Public title: Investigation of High Resolution Nuclear Breast Imaging Camera (MBI) in Patients Administered Tc-99m Sestamibi (ROSE) ROSE
Scientific title: A Pilot, Single Centre, Prospective Clinical Study Investigation of the Acceptability of a Dedicated High Resolution Nuclear Breast Imaging Camera (MBI) in Breast Imaging of Patients Administered Tc-99m Sestamibi (ROSE)
Date of first enrolment: March 2012
Target sample size: 150
Recruitment status: Recruiting
URL:  http://clinicaltrials.gov/show/NCT01368939
Study type:  Observational
Study design:  Observational Model: Cohort, Time Perspective: Prospective  
Countries of recruitment
Canada
Contacts
Name:   Tammy Murray, Research Officer
Address: 
Telephone: 905-522-1155
Email: tmurray@stjosham.on.ca
Affiliation: 
Name:   Tammy Murray
Address: 
Telephone: 905-522-1155
Email: tmurray@stjosham.on.ca
Affiliation: 
Name:   Amit Singnurkar, MD, FRCPC
Address: 
Telephone:
Email:
Affiliation:  HHSC, McMaster University, St. Joseph's Healthcare
Key inclusion & exclusion criteria

Inclusion Criteria:

- females over 18 years of age

- completed a cardiac stress test using Tc-99m Sestamibi as the radiotracer prior to
MBI imaging on the same day.

- signed consent form

Exclusion Criteria:

- pregnant or lactating

- history of invasive breast cancer or ductal carcinoma in situ

- prior bilateral mastectomy

- prior breast biopsy or surgery within 3 months

- any other conditions that based on the investigator's judgement, may impact the
ability of the patient to complete the study



Age minimum: 18 Years
Age maximum: N/A
Gender: Female
Health Condition(s) or Problem(s) studied
Breast Lesions
Intervention(s)
Primary Outcome(s)
Secondary Outcome(s)
Secondary ID(s)
HHSC-CPDC-001
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history